Introduction
The measurement of homocysteine (HCy) is of importance in both research and clinical laboratories carrying out assessments for vascular risk and thrombophilia, and monitoring of patients with homocystinuria. In the current study we have assessed the e¡ectiveness of 3-deazaadenosine (3-DAA), as a preservative of plasma total homocysteine (tHCy) in whole blood samples at room temperature and when cooled.
Methods
Local Ethics Committee Approval was obtained for all procedures. Five in-house volunteers were provided with an information sheet and verbal consent acquired for venepuncture. Tubes (22 Â2.5 mL) containing EDTA (NHS Supplies) and 22 Â3 mL tubes containing EDTA þ 3DAA (Drew Scienti¢c, Cumbria, UK) were obtained (121mL of blood per individual). One tube from each volunteer was immediately centrifuged at 2800 r.p.m. for 10 min and the plasma separated, labelled and stored in 300 mL aliquots at À801C. Eight from each group were maintained at room temperature in a drawer away from draughts and out of the light; eight were maintained on the middle shelf of a refrigerator (0--41C); and the remaining ¢ve were placed in a Styrofoam transport box and packed with cold packs, ensuring that the frozen packs did not come into direct contact with the blood vials. Samples were separated and analysed at time points 6, 12, 24, 48, 72, 96, 120 and 168 h using an Abbott IMx analyzer 1 (Abbott Laboratories, Berkshire, UK). For the tubes maintained in cold packing, the tubes were treated in the same manner at time points 12, 24, 48, 72 and 96 h.
Statistical analysis
The data were analysed using the Student's t-test compared with time point 0. An analysis of variance (ANO-VA) was used to compare results from each group. All analyses were performed using Minitab 13 software.
Results
In samples maintained at room temperature, the tHCy concentrations were signi¢cantly di¡erent (Po0.001) at all time points from the initial 6-h assessment assay. There was a mean percentage increase in tHCy of 29.4% at 6 h, increasing to 242.6% after 168 h (7 days). Storing the samples in the refrigerator or cool packing signi¢cantly inhibited a change in tHCy in the blood samples tested when compared with time point 0, and when compared with samples stored at room temperature (ANOVA Po0.001 for all). When the samples were placed in the fridge at 0--41C, a signi¢cant change did not occur until after 72 h, while samples stored in the cold packs did not signi¢cantly change until after 48 h (Table 1) .
3DAA had a signi¢cant preservative e¡ect (ANOVA Po0.001). At room temperature, a signi¢cant di¡erence from control occurred after 48 h, while in samples placed in the refrigerator a signi¢cant change did not occur until after 120 h, and samples stored in the cold packs did not signi¢cantly change during the time assessed (96 h). There was a signi¢cant interaction between the e¡ect of cooling and the addition of 3DAA (ANOVA Po0.001).
Control samples were assayed with and without added 3DAA. There was no signi¢cant di¡erence between the control sets, although the means (7SEM) of the samples containing 3DAAwere lower than those without (7.7271.72mmol/L versus 7.2672.35 mmol/L, P ¼ 0.73). In addition, there was close correlation between the two groups (Pearson's correlation coe⁄cient r ¼ 0.77, Po0.001).
Discussion
Our ¢ndings are consistent with those of other authors who have reported 10--20% increases after only 1h, increasing to 75--170% after 24 h. 1 The rate of increase of tHCy in whole blood is almost constant, independent of the tHCy, which would lead to larger errors at lower tHCy. 2 This has serious implications for the value of analyses made in patients with high normal/low abnormal tHCy if samples are not rigorously processed at the time of sampling.
In our study, refrigeration appeared to stabilize plasma tHCy for 72 h, while storage in cool packs maintained tHCy for 48 h. In the Hill et al. 3 study, refrigeration of samples (n ¼ 59) analysed at 3,6, 24 and 72 h could only maintain stability for 3 h; however, aliquots were removed from a single sample of blood, which would therefore have been regularly removed from the refrigerator to room temperature and mixed prior to sampling. It is di⁄cult to assess the potential impact, if any, this handling may have had on plasma tHCy. Storage of whole blood for homocysteine assay Al-Khafaji et al. 4 observed that 3DAAwas e¡ective in preserving whole blood tHCy for at least 24 h and reduced increases to less than10% at 72 h at room temperature. Hill et al. 3 also demonstrated preservation of plasma tHCy for 72 h (n ¼ 59) in samples stored at room temperature, but observed that the tHCy could be preserved for one week if stored at 2--41C. 3DAA is a competitive inhibitor of SAHH (S-adenosyl homocysteine hydrolase), the ¢nal step in the production of HCy, preventing conversion of SAH (S-adenosyl homocysteine) to HCy. However, as precursors of HCy build up, they eventually overcome 3DAA inhibition. Slowing of red blood cell metabolism by cooling signi¢cantly extended the stability of HCy in whole blood. In our study, the addition of 3DAA extended HCy stability from o6 to 48 h at room temperature, and from 3--5 days if kept refrigerated. Woltersdorf et al. 5 showed a dose-dependent decrease in tHCy assessment with the addition of 0--1000 mmol/L of 3DAA (n ¼1), and an 8.8% reduction in apparent tHCy at 100 mmol/L (n ¼17). Dawling 6 observed a similar dose-dependent decrease in a pooled blood sample to which 0.1--1667 mmol/L of 3DAA was added, with a 13% decrease at 100 mmol/L. This is consistent with competitive inhibition of SAHH. In our study, using 100 mmol/L of 3DAA, there was no signi¢cant di¡erence between results obtained with and without preservative (r ¼ 0.77, Po0.001), although results from tubes containing preservative tended to be lower in the control set. The conversion of HCy to SAH in the Abbott £uorescence polarization immunoassay (FPIA) is driven by supraphysiological concentrations of adenosine, which the manufacturers feel should prevent such interference. Larger studies are required to clarify this potential source of error.
Our pilot data would suggest that the preservative 3DAA signi¢cantly preserves HCy concentrations in whole blood and does not appear to interfere with the Abbott immunoassay. Larger population studies, involving a larger range of tHCy concentrations are required to validate this data. However, until a standard for HCy assay is agreed, meaningful comparisons of HCy concentrations derived from di¡erent laboratories will continue to be di⁄cult.
